Content Detail

• Content META

  Title	GLOBAL MEDICAL REIT INC. Global Medical REIT : Supplemental Presentation FY 2024
  ID	7343154
  External ID	7586928840
  Author	Unknown
  Published Date	Feb. 27, 2025, 3:31 p.m.
  Summary	February 27, 2025 at 04:23 pm EST Atrium Health - Winston-Salem, NC FOURTH QUARTER 2024 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE TABLE OF CONTENTS Legent Hospital for Special
  Tags	None
  URL	https://www.marketscreener.com/quote/stock/global-medical-reit-inc-29159907/news/global-medical-reit-supplemental-presentation-fy-2024-49189988/
  Sentiment	Negative: 0.03821    Neutral: 0.93749    Positive: 0.02430
  Relevance	0.03863

• Content Details

  Content ID	4648400
  Key	36726217-e297-4ea4-947d-500af3c99c7c
  Content	February 27, 2025 at 04:23 pm EST Atrium Health - Winston-Salem, NC FOURTH QUARTER 2024 EARNINGS SUPPLEMENTAL www.globalmedicalreit.com NYSE: GMRE TABLE OF CONTENTS Legent Hospital for Special Surgery - Plano, TX Forward-Looking Statements Certain statements contained herein may be considered "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, and it is the Company's intent that any such statements be protected by the safe harbor created thereby. These forward-looking statements are identified by their use of terms and phrases such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," "plan," "predict," "project," "will," "continue" and other similar terms and phrases, including references to assumptions and forecasts of future results. Except for historical information, the statements set forth herein including, but not limited to, any statements regarding our earnings, our liquidity, our tenants' ability to pay rent to us, expected financial performance (including future cash flows associated with our joint venture, new tenants or the expansion of current properties), future dividends or other financial items; any other statements concerning our plans, strategies, objectives and expectations for future operations and future portfolio occupancy rates, our pipeline of acquisition opportunities and expected acquisition activity, including the timing and/or successful completion of any acquisitions and expected rent receipts on these properties, our expected disposition activity, including the timing and/or successful completion of any dispositions and the expected use of proceeds therefrom, and any statements regarding future economic conditions or performance are forward-looking statements. These forward-looking statements are based on our current expectations, estimates and assumptions and are subject to certain risks and uncertainties. Although the Company believes that the expectations, estimates and assumptions reflected in its forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of the Company's forward-looking statements. Additional information concerning us and our business, including additional factors that could materially and adversely affect our financial results, include, without limitation, the risks described under Part I, Item 1A - Risk Factors, in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q, and in our other filings with the SEC. You are cautioned not to place undue reliance on forward-looking statements. The Company does not intend, and undertakes no obligation, to update any forward-looking statement. COMPANY OVERVIEW GLOBAL MEDICAL REIT INC. (GMRE) IS A NET-LEASE MEDICAL REAL ESTATE INVESTMENT TRUST (REIT) THAT ACQUIRES HEALTHCARE FACILITIES AND LEASES THOSE FACILITIES TO PHYSICIAN GROUPS AND REGIONAL AND NATIONAL HEALTHCARE SYSTEMS. Blue Sky Vision - Grand Rapids, MI PORTFOLIO SNAPSHOT (as of December 31, 2024) COMPANY OVERVIEW Executive Officers Jeffrey Busch Robert Kiernan Alfonzo Leon Danica Holley Jamie Barber Board of Directors Jeffrey Busch Henry Cole Paula Crowley Matthew Cypher, Ph.D. Ronald Marston Lori Wittman Zhang Huiqi INDEPENDENT DIRECTORS Chairman, Chief Executive Officer and President Chief Financial Officer and Treasurer Chief Investment Officer Chief Operating Officer General Counsel and Corporate Secretary Chairman of the Board, Chief Executive Officer and President ESG Committee Chair, Compensation Committee Member, Audit Committee Member, Nominating and Corporate Governance Committee Member Compensation Committee Chair, Audit Committee Member, Nominating and Corporate Governance Committee Member Nominating and Corporate Governance Committee Chair, ESG Committee Member, Audit Committee Member Nominating and Corporate Governance Committee Member, Compensation Committee Member Lead Independent Director, Audit Committee Chair, ESG Committee Member Director BOARD % OF WOMEN COMPANY OVERVIEW Corporate Headquarters Global Medical REIT Inc. 7373 Wisconsin Avenue, Suite 800 Bethesda, MD 20814 Phone: 202.524.6851 www.globalmedicalreit.com Stock Exchange New York Stock Exchange Ticker: GMRE Investor Relations Stephen Swett Phone: 203.682.8377 Email: stephen.swett@icrinc.com Independent Registered Public Accounting Firm Deloitte & Touche LLP McLean, VA Corporate and REIT Tax Counsel Vinson & Elkins LLP Daniel LeBey, Corporate Partner Christopher Mangin, REIT Tax Partner Transfer Agent Equiniti Trust Company Phone: 800.468.9716 4Q-2024 | Earnings Supplemental Sell-Side Analyst Coverage Cobalt Rehabilitation Hospital - Surprise, AZ SELECT QUARTERLY FINANCIAL DATA (unaudited, and in thousands, except per share and unit amounts) BUSINESS SUMMARY FOURTH QUARTER 2024 OPERATING SUMMARY Net income attributable to common stockholders was $1.4 million, or $0.02 per diluted share, as compared to net loss attributable to common stockholders of $0.8 million, or $0.01 per diluted share, in the comparable prior year period. The results for the fourth quarter of 2024 included an aggregate gain on sale of investment properties of $5.8 million, a charge for $3.2 million in costs related to CEO severance and transition, and a non- cash impairment charge of $1.7 million on one of our properties, while the fourth quarter 2023 results included a loss on the extinguishment of debt of $0.9 million. Funds from Operations attributable to common stockholders and noncontrolling interest ("FFO") of $11.1 million, or $0.15 per share and unit, as compared to $13.3 million, or $0.19 per share and unit, in the comparable prior year period. Adjusted Funds from Operations attributable to common stockholders and noncontrolling interest ("AFFO") of $15.8 million, or $0.22 per share and unit, as compared to $15.9 million, or $0.23 per share and unit, in the comparable prior year period. INVESTMENT AND PORTFOLIO ACTIVITY During the fourth quarter of 2024, the Company completed the acquisition of the remaining 10 properties in the 15-property portfolio encompassing 159,726 leasable square feet for an aggregate purchase price of $49.5 million and annualized base rent of $3.9 million. In aggregate the 15-property portfolio had a purchase price of $80.3 million with 254,220 leasable square feet and annualized base rent of $6.4 million. As previously announced, the Company entered into a purchase agreement to acquire a five-property portfolio for an aggregate purchase price of $69.6 million at a cap rate of 9.0%. As of February 26, 2025, the Company completed the acquisition of three of the five properties for an aggregate purchase price of $31.5 million. The Company expects to complete the acquisition of the remaining two properties during the second quarter of 2025. The Company's obligation to close the remainder of this acquisition is subject to certain customary terms and conditions. Accordingly, there is no assurance that the Company will close the remainder of this acquisition on a timely basis or at all. During the fourth quarter of 2024, the Company entered into a joint venture (the "Joint Venture") with Heitman Capital Management LLC ("Heitman") and sold two properties to the Joint Venture, generating $35.2 million of gross proceeds, and completed the disposition of two additional properties generating gross proceeds of $5.3 million, resulting in an aggregate gain from the four dispositions of $5.8 million. For the full year 2024, the Company completed seven dispositions, including the two properties sold to the Joint Venture, generating aggregate gross proceeds of $60.7 million, resulting in an aggregate gain on sale of $4.2 million. The weighted average cap rate of the Company's 2024 dispositions was 9.0%. CAPITAL MARKETS AND DEBT ACTIVITY Leverage was 44.8% as of December 31, 2024. As of February 26, 2025, we had unutilized borrowing capacity under the Credit Facility of $219 million. During the year ended December 31, 2024, the Company issued 1.2 million shares of its common stock through its ATM program at an average offering price of $9.95 per share, generating gross proceeds of $12.0 million. ACQUISITIONS / DISPOSITIONS (as of February 26, 2025) Acquisitions Under Contract As previously announced, the Company entered into a purchase agreement to acquire a five-property portfolio for an aggregate purchase price of $69.6 million at a cap rate of 9.0%. As of February 26, 2025, the Company completed the acquisition of three of the five properties for an aggregate purchase price of $31.5 million (see the table above). The Company expects to complete the acquisition of the remaining two properties during the second quarter of 2025. The Company's obligation to close the remainder of this acquisition is subject to certain customary terms and conditions. Accordingly, there is no assurance that the Company will close the remainder of this acquisition on a timely basis or at all. Dispositions During the fourth quarter of 2024, the Company entered into the Joint Venture with Heitman and sold two properties to the Joint Venture, generating $35.2 million of gross proceeds, and completed the disposition of two additional properties generating gross proceeds of $5.3 million, resulting in an aggregate gain from the four dispositions of $5.8 million. For the full year 2024, the Company completed seven dispositions, including the two properties sold to the Joint Venture, generating aggregate gross proceeds of $60.7 million, resulting in an aggregate gain on sale of $4.2 million. The weighted average cap rate of the Company's 2024 dispositions was 9.0%. Pediatrics Plus - Russellville, AR PORTFOLIO SUMMARY (as of December 31, 2024) PORTFOLIO STATISTICS Texas Digestive Disease Consultants- Ft. Worth, TX St Joesph's Medical Plaza - Tucson, AZ Mercy Rehab Hospital - Oklahoma City, OK TENANT COMPOSITION % of ABR* PORTFOLIO SUMMARY (as of December 31, 2024) cCare - San Marcos, CA LEASE TYPE % of ABR* RENT COVERAGE* Hialeah Medical Plaza - Hialeah, FL 1) Includes surgical hospitals, long-term acute care hospitals (LTACH) and behavioral hospitals. 4Q-2024 | Earnings Supplemental *See page 21 for disclosure regarding the Company's Annualized Base Rent (ABR) 10 and page 22 for disclosure regarding the Company's rent coverage calculation Attachments Original document Permalink Disclaimer Global Medical REIT Inc. published this content on February 27, 2025 , and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on February 27, 2025 at
  Content Reference URL	None

• Publisher

  Publisher Name	MarketScreener
  Publisher URL	http://www.marketscreener.com
  Description	None
  Trust Flow Score	23
  Citation Flow Score	26

• Data Source

  Data Source Name	Quantexa News
  Data Source Type	news
  Data Source URL	https://app.aylien.com/dashboard
  Description	Welcome to Quantexa News API — the most powerful way to aggregate, filter, and integrate global news data into your apps and models.
  Weight	10